Skip to main content
Explore URMC
menu

News

20212020201920182017

$2M Grant Supports CMSR Study of Biologic Factors in Tendon Healing

Thursday, July 29, 2021

A team in the Center for Musculoskeletal Research will use a 5-year, $2 million grant from the National Institute of Health and NIAMS to expand a promising avenue of scientific exploration: the cell biology of tendon healing.

Read More: $2M Grant Supports CMSR Study of Biologic Factors in Tendon Healing

Caroline Thirukumaran Authors JAMA Viewpoint on Disparities in Medicare Joint Surgery

Friday, July 23, 2021

Elective total hip and knee replacements (“joint replacements”) are effective treatments for end-stage osteoarthritis. Because of the clinical benefits of these procedures, racial and ethnic– and income-based disparities in the use and outcomes of these surgical procedures are particularly troubling. The Triple Aim framework, which conveys the idea that health systems need to simultaneously optimize over multiple interlinked yet diverse goals including care experience, population health, and per-capita costs,3 may provide a model for incorporating disparity reduction into the goals of payment reform.

Read More: Caroline Thirukumaran Authors JAMA Viewpoint on Disparities in Medicare Joint Surgery

NIH ‘seed money’ for early researchers yields rich returns for CMSR

Monday, June 14, 2021

Any organization that gets a 42-fold return on investment is doing something right -- actually, doing a lot of things right. That's the story of the Center for Musculoskeletal Research, which marked its 20th anniversary in November 2020. Among many achievements worth celebrating: turning $500,000 in P30 pilot grants for young investigators into $21 million in NIH funding over a 5-year period (see chart).

In early June 2021, The Department of Orthopaedics research center got another reason to cheer: notification from NIH that its 800-page P30 grant renewal application was accepted, and it had earned continued funding. The 5-year grant includes $2,499,995 direct costs, and $3,849,995 total costs.

"We have many grants at the Center, but the P30 is a backbone," said Edward M. Schwarz, Ph.D., Richard and Margaret Burton Distinguished Professor of Orthopaedics and Director of the Center for Musculoskeletal Research. "It's an infrastructure grant that doesn't directly fund research but makes our research possible."

Read More: NIH ‘seed money’ for early researchers yields rich returns for CMSR